Iovance Biotherapeutics I...

AI Score

XX

Unlock

3.21
0.13 (4.22%)
At close: Apr 22, 2025, 3:59 PM
3.30
2.96%
Pre-market: Apr 23, 2025, 06:21 AM EDT

Iovance Biotherapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
164.07M 1.19M n/a n/a n/a n/a n/a n/a n/a
124M 10.76M 21.14M 13.98M 8.71M 8.12M 956K 952K 978K
40.08M -9.57M -21.14M -13.98M -8.71M -8.12M -956K -952K -978K
-395.28M -460.56M -398.88M -342.7M -261.94M -206.87M -128.26M -92.88M -53.64M
20.27M 13.04M 2.98M 451K 2.36M 9.32M n/a 813K 745K
-375M -447.52M -395.89M -342.25M -259.58M -197.56M -123.58M -92.06M -52.89M
-372.18M -444.04M -389.92M -327.82M -257.23M -187.07M -123.58M -92.06M -52.89M
153.02M 106.92M 104.1M 83.66M 60.21M 40.85M 28.43M 21.26M 25.6M
282.34M 344.08M 294.78M 259.04M 201.73M 166.02M 99.83M 71.61M 28.04M
n/a n/a n/a n/a n/a n/a n/a n/a n/a
435.35M 450.99M 398.88M 342.7M 261.94M 206.87M 128.26M 92.88M 53.64M
n/a n/a 2.98M n/a n/a n/a n/a n/a n/a
n/a 79.22M n/a n/a n/a n/a n/a n/a n/a
559.35M 461.75M 398.88M 342.7M 261.94M 206.87M 128.26M 92.88M 53.64M
-2.83M -3.48M -5.97M -14.43M -2.36M -10.48M 4.68M -952K -978K
289.88M 235.13M 159.26M 153.41M 138.3M 124.34M 97.28M 65.24M 55.27M
289.88M 235.13M 159.26M 153.41M 138.3M 124.34M 97.28M 65.24M 55.27M
-1.28 -1.89 -2.45 -2.14 -1.86 -1.5 -1.27 -1.41 -0.96
-1.28 -1.89 -2.45 -2.14 -1.86 -1.5 -1.27 -1.41 -0.96
-395.28M -427.43M -374.76M -328.27M -250.87M -189.43M -122.62M -91.11M -51.92M
-395.28M -460.56M -395.89M -342.25M -259.58M -197.56M -123.58M -92.06M -52.89M
n/a 33.13M 21.14M 13.98M 8.71M 8.12M 956K 952K 978K